MJBizDaily’s recent piece argues that the cannabis industry must give genetics a strategic role beyond marketing. For breeders, seedbanks and commercial growers that means clear provenance, investment in breeding and data, and active stewardship to protect diversity, IP and supply resilience. This editorial explains what the argument means in practical terms for professionals and where the industry will need attention next.

MJBizDaily has highlighted a simple proposition: genetics are the cannabis industry’s most valuable asset. For breeders, seedbanks, producers and distributors that claim to sell consistency, potency or therapeutic value, that statement should change how contracts, quality assurance and corporate strategy are organised.